NPI: 1730555699 · CLEVELAND, MS 38732 · 363LF0000X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 502 | $20K |
| 2019 | 443 | $18K |
| 2020 | 683 | $26K |
| 2021 | 3,248 | $92K |
| 2022 | 8,804 | $107K |
| 2023 | 4,210 | $106K |
| 2024 | 1,036 | $27K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | 6,778 | 4,976 | $303K | |
| 87426 | 944 | 632 | $16K | |
| 96372 | 2,091 | 1,584 | $15K | |
| J2010 | Lincomycin injection | 1,229 | 964 | $15K |
| 87428 | 236 | 226 | $13K | |
| G2023 | Specimen collect covid-19 | 835 | 616 | $10K |
| 87804 | 1,503 | 474 | $9K | |
| 85025 | 1,655 | 1,216 | $6K | |
| 81025 | 861 | 626 | $4K | |
| J0702 | Betamethasone acet&sod phosp | 631 | 444 | $3K |
| 81001 | 683 | 476 | $1K | |
| 99202 | 12 | 12 | $607.10 | |
| J1100 | Dexamethasone sodium phos | 1,198 | 952 | $365.84 |
| 87807 | 126 | 59 | $286.47 | |
| 86580 | 14 | 12 | $83.28 | |
| J0696 | Ceftriaxone sodium injection | 82 | 67 | $50.96 |
| 83036 | 48 | 13 | $0.00 |